tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nick Abbott, 8 are a HOLD (66.67%), 4 are a BUY (33.33%).
Analyst Nick Abbott, carries an average stock price target met ratio of 75% that have a potential upside of 44.78% achieved within 315 days. Previously, Nick Abbott worked at WELLS FARGO.
Nick Abbott’s has documented 21 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 30-May-2023.
Analyst best performing recommendations are on IOVA (IOVANCE BIOTHERAPEUTICS).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 2/26/2020. The price target of $38 was fulfilled within 9 days with a profit of $4.35 (12.93%) receiving and performance score of 14.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Jan-2022
$80
$-110.01 (-57.90%)
$60
3 days ago
(30-Sep-2026)
26/27 (96.3%)
$-112.57 (-58.46%)
288
5.36
Hold Since 03-Sep-2026
$81
$-109.01 (-57.37%)
$165
1 months ago
(03-Sep-2026)
1/2 (50%)
$-67.87 (-45.59%)
2
11.2
Hold Since 28-Aug-2026
$180
$-10.01 (-5.27%)
1 months 5 days ago
(28-Aug-2026)
8/8 (100%)
$42.01 (30.44%)
156
6.35
Sell Since 15-Nov-2024
$25
1 months 8 days ago
(25-Aug-2026)
2/2 (100%)
$-7.99 (-24.22%)
30
8.39
Hold Since 13-Feb-2026
$125
$-65.01 (-34.21%)
$45
1 months 9 days ago
(24-Aug-2026)
15/19 (78.95%)
$-13.89 (-10.00%)
366
5.94
